Warren Buffett's Berkshire Hathaway Inc (NYSE:BRK.B) is nearing an agreement to buy OxyChem, a division of Occidental Petroleum Corp (NYSE:OXY), for about $10 billion, The Wall Street Journal reported late Tuesday. If finalized, the acquisition would be Berkshire's largest since 2022 when it bought insurer Alleghany for $11.6 billion.

Big tech giant Amazon.com Inc (NASDAQ:AMZN) just staged a short-term pullback after brushing up against the $240 region, home to its Feb. 4 record high of $242.52.

Atai Life Sciences N.V. has surged >275% YTD, driven by promising psychedelic drug candidates targeting treatment-resistant depression and other mental health disorders. ATAI's lead asset, BPL-003, shows strong, durable efficacy in early trials, potentially surpassing Spravato, but regulatory and scheduling hurdles remain significant risks. Despite a tight cash position and upcoming milestones, ATAI's valuation may be fair or slightly overvalued, with major catalysts like Phase 2b/3 data and FDA discussions ahead.

Uncle Sam may have just launched the most unconventional ETF on Wall Street (hypothetical, of course). With equity stakes in Intel Corp (NASDAQ:INTC) and Lithium Americas Corp (NYSE:LAC), the U.S. government is shifting from backroom subsidies to front-row ownership — and investors are taking notice.

The New York Times continues to impress with strong digital subscriber growth and rising average revenue per user, defying industry headwinds. NYT's Q2 revenue grew 9.7% year-over-year, beating expectations, with bundle subscribers and successful promotional conversions driving ARPU higher. New licensing deals, like the recent Amazon partnership, and AI-driven newsroom efficiencies present potential catalysts for future EPS acceleration.

If you tell Amex you want to cancel, the company might offer you some cash, points or miles as an incentive to keep your card.

LOS ANGELES--(BUSINESS WIRE)---- $MLTX--MLTX Investors Have Opportunity to Join MoonLake Immunotherapeutics Fraud Investigation with the Schall Law Firm.

SAN FRANCISCO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- A new securities class action lawsuit has been filed against KinderCare Learning Companies, Inc. (NYSE: KLC) and its executives, alleging the company misled investors during its October 2024 Initial Public Offering (IPO). The lawsuit, styled Gollapalli v. KinderCare Learning Companies, Inc., et al., seeks to represent investors who purchased KLC common stock in or traceable to the company's IPO.

Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.

SAN FRANCISCO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results. The litigation, filed in a Texas federal court, alleges that Nutex collaborated with third-party billing firm HaloMD to submit ineligible insurance claims, misleading shareholders and triggering substantial losses.

SLQT Investors with Losses Encouraged to Contact the Firm Before Oct. 10th Deadline SLQT Investors with Losses Encouraged to Contact the Firm Before Oct. 10th Deadline

AES (AES) shares jumped 16% Wednesday afternoon following a report the renewable energy provider is in talks to be acquired by BlackRock's (BLK) Global Infrastructure Partners (GIP).

The October 2025 high-yield dividend watchlist highlights 10 stocks with an average forward yield of 3.95% and a projected 19.02% return. This month's selection process lowered the yield threshold to 2.5%, expanding the pool to 69 companies and increasing diversification opportunities. The watchlist has delivered a 15.01% CAGR since inception, outperforming its 12% target and offering higher starting yields than SPY and VYM.

Netflix is facing calls of a boycott from Elon Musk over an animated show it aired that featured a transgender character.

Will HBAN's expansion through acquisitions, as well as major expansions into Texas, the Carolinas, and Florida, drive growth? Let us find out.

PepsiCo has faced a challenging 2025, underperforming the S&P 500 and grappling with negative sentiment around consumer trends and weight-loss drugs. Elliot Management's $4B investment signals belief in a turnaround, pushing for cost cuts, brand focus, and a potential bottling spin-off to emulate KO's model. Q3 2025 is pivotal for PEP, with investor focus on management's response to Elliot's proposals and progress in healthier product offerings like Poppi and prebiotic sodas.

Rising gasoline inventories put additional pressure on oil markets.

Amplify Alternative Harvest ETF is my top cannabis ETF pick due to its diversification and positive response to rescheduling headlines. I expect President Trump to leverage cannabis rescheduling for midterm election gains, which should boost MJ and other cannabis ETFs in the near term. MSOS is downgraded to sell due to high concentration risk, while CNBS is rated a hold because of its reliance on swaps and high expense ratio.

Investors love dividend stocks, especially high-yield varieties, because they offer a significant income stream and have substantial total return potential.

As DoorDash moves into new lines of business, delivery services from apps are starting to overlap — but one analyst notes “good companies run these kinds of experiments.”